最新消息
葳蔓诗集官方论坛-干细胞外泌体护肤交流平台

尊敬的各位嘉宾、朋友们: 欢迎来到葳蔓诗集官方论坛!感谢大家对我们的关注与支持。葳蔓诗集专注于干细胞外泌体技术,致力于开发高效护肤产品。我们的团队拥有十余年的研发经验,致力于生物科技与皮肤医学的研究。 在这个论坛中,我们希望通过互动与交流,推动护肤科技的发展。请随时提出疑问,分享心得,我们的专业团队将竭诚为您服务。 再次感谢大家的到来,期待与您深入交流,共同见证葳蔓诗集的持续创新与进步。 谢谢大家!

Global Pioneer in Exosome Technology — Guangzhou Lanyuan Elai Mei Biotechnology Seeks Strategic Partners! High-Potential Sector · Top-Tier Scientific

Panda

官方行政人员
管理成员
我司认证的人员,拨打我司电话可以查询到工号的。
提供给我司的产品建议,并且获得我司认可的用户。
**Who Are We?**
Guangzhou Lanyuan Elai Mei Biotechnology Co., Ltd. is a national high-tech enterprise dedicated to the R&D and application of exosome technology. Guided by the core philosophy of "scientific innovation + commercialization," we are committed to translating cutting-edge biotechnology into solutions that enhance human health and quality of life.

**A Decade of Dedication**
- **Deep Expertise**: 10 years of R&D experience in exosome technology with robust technical积累.
- **Elite Team**: Led by world-class scientists and clinical experts, with patented technologies spanning the entire industry chain.
- **Full-Scenario Ecosystem**: Businesses cover medical devices, pharmaceutical ingredients, innovative skincare, and targeted drug development, forming a closed-loop exosome ecosystem.

**🌟 Core Brand — Wiman Poem Collection**
*Redefining Science-Backed Skincare!*
Leveraging stem cell-derived exosome technology, we develop high-efficacy anti-aging and reparative skincare products:
✅ **Technical Edge**: Proprietary exosome extraction and stabilization technology, clinically validated for efficacy.
✅ **Market Appeal**: Over 60% repurchase rate in premium medical aesthetics channels, with viral user-approved products.
✅ **Regulatory Advantage**: Medical device-grade quality, compliance-ready for medical aesthetics institutions, high-end e-commerce, and more.

**💡 Why Partner With Us?**
**1. Globally Leading Technology**
- Pioneering exosome mass production and targeted delivery systems with cost advantages.
- Internationally certified (ISO13485, FDA filings), fully compliant.
**2. Full-Category Coverage, High Profit Potential**
- Four sectors: Medical devices (e.g., dressings/regenerative materials), cosmetic ingredients (exosome serums), skincare (Wiman Poem Collection), and innovative drugs.
- Customizable partnerships: Single-category or full-range agency options.
**3. End-to-End Support, Shared Risk**
- Sales activation: Academic resources, clinical case studies, and training systems.
- Channel protection: Exclusive regional distribution, strict anti-diversion policies.
- Flexible terms: First-order discounts, unsold product exchanges, quarterly rebates of up to 15%.

**🤝 Ideal Partners**
- **Channels**: Medical aesthetics clinics, premium pharmacies, cross-border e-commerce, biotech原料 suppliers.
- **Vision**: Believe in exosome technology’s potential and willing to co-develop the market.
- **Models**: Brand distribution, OEM customization, joint R&D, or原料 supply.

**🚀 Partnership Process**
1. **Consultation**: Submit intent to receive product whitepaper and policies.
2. **Onsite Visit**: Tour GMP-certified facilities and meet technical experts.
3. **Launch**: Customized plan + startup kit (worth ¥100,000: promotional resources + training).

**📩 Seize the Exosome Revolution Now!**
**Contact Us**
- Hotline: Mr. Huang 15068297797 (WeChat same as phone)
- Address: Room 803A (1956), 1268 Guangzhou Avenue Middle, Tianhe District, Guangzhou
- Website: www.wmauty-talk.com

**✨ Limited-Time Benefits**
First 5 partners receive:
✅ Exclusive exosome masterclass (taught by academicians).
✅ ¥200,000 first-year advertising subsidy!

**【Core Messaging】**
- Highlight **technical superiority** and **market uniqueness**: Position exosomes as the next frontier in biopharma and medical aesthetics, emphasizing "global leadership" and "full-chain integration."
- **Mitigate risks**: Certifications, clinical data, and flexible return policies to reassure partners.
- **Multi-channel appeal**: Tailored entry points for medical aesthetics,原料 buyers, and cross-border players.

**Join Lanyuan Elai Mei to redefine the future with technology and share in the trillion-dollar exosome opportunity!**
 
后退
顶部